Narrow search
Showing 1 - 10 of 182,325
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
COVID-19 vaccines and the role of patents
Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491
Persistent link: https://www.econbiz.de/10012800211
Cover Image
Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation
Vertinsky, Liza - 2015
Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …
Persistent link: https://www.econbiz.de/10014136820
Cover Image
Knowledge production and commercialization from R&D : the pharmaceutical sector
García Valderrama, Teresa; Sánchez Ortiz, Jaime; … - In: Management decision 61 (2023) 13, pp. 222-247
Persistent link: https://www.econbiz.de/10014448293
Cover Image
Appropriate industrial technology for drugs and pharmaceuticals
1980
Persistent link: https://www.econbiz.de/10012880645
Cover Image
The EU's open strategic autonomy in the field of pharmaceuticals : overcoming import dependencies for antibiotics through the EU authority HERA
Bayerlein, Michael - Stiftung Wissenschaft und Politik - 2023
The COVID-19 pandemic and war in Ukraine have highlighted the dependence of the European Union (EU) on individual trading partners. One of the tasks of the European Commission’s new Directorate-General, the Health Emergency Preparedness and Response Authority (HERA), established in 2021, will...
Persistent link: https://www.econbiz.de/10013540432
Cover Image
Is Europe a Laggard in Pharmaceuticals? R&D Joint Ventures, Patent Quality and R&D Productivity
Messinis, George - 2009
‘performed' R&D and ‘extra-mural' R&D, and focuses on R&D productivity and patent quality as key indicators of innovation. The …
Persistent link: https://www.econbiz.de/10013155663
Cover Image
Patent Quality and R&D Productivity in Pharmaceuticals : The Role of Inflation and International Collaboration
Messinis, George - 2009
Lanjouw and Schankerman (2004) proposed that patent quality is a key driver of R&D productivity but did not find supportive evidence for pharmaceuticals. This study revisits this hypothesis using OECD data for the period 1980-2000. It extends the literature in three ways: it develops new R&D...
Persistent link: https://www.econbiz.de/10013155664
Cover Image
Excessive Pharmaceutical Prices and Competition Law : Doctrinal Development to Protect Public Health
Abbott, Frederick M. - 2017
Persistent link: https://www.econbiz.de/10012970248
Cover Image
Biopharma in China : Innovation, Trends and Dealmaking
Agten, Sven; Wu, Ben - 2024
and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma …: Explosive growth in a thriving ecosystem -- Chapter 4: Innovation in the Chinese biopharma: From me-too to First … country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of …
Persistent link: https://www.econbiz.de/10014519028